Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPOP: Blind Sciatic Nerve Block vs Morphine
NCT01522534Phase 3Terminated
- Sponsor
- Centre Hospitalier Annecy Genevois
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mepivacaine in acute pain, sponsored by Centre Hospitalier Annecy Genevois. Started Jan 2012; status: terminated.
02
Drugs
mepivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01522534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522534.